SIG
CME icon

Stonegate Investment Group’s CME Group CME Stock Holding History

Stonegate Investment Group’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$387K Buy
1,432
+8
+0.6% +$2.18K 0.01% 283
2025
Q2 		$392K Sell
1,424
-39
-3% -$10.6K 0.01% 271
2025
Q1 		$388K Buy
1,463
+92
+7% +$22.7K 0.01% 248
2024
Q4 		$318K Sell
1,371
-58
-4% -$13.3K 0.01% 260
2024
Q3 		$315K Hold
1,429
– – 0.01% 273
2024
Q2 		$281K Hold
1,429
– – 0.01% 280
2024
Q1 		$308K Hold
1,429
– – 0.01% 258
2023
Q4 		$301K Sell
1,429
-297
-17% -$63.4K 0.01% 251
2023
Q3 		$346K Hold
1,726
– – 0.01% 230
2023
Q2 		$320K Sell
1,726
-416
-19% -$76.9K 0.01% 243
2023
Q1 		$410K Sell
2,142
-266
-11% -$48.1K 0.02% 222
2022
Q4 		$405K Sell
2,408
-972
-29% -$169K 0.02% 220
2022
Q3 		$599K Sell
3,380
-135
-4% -$26.7K 0.03% 168
2022
Q2 		$720K Sell
3,515
-117
-3% -$24.8K 0.03% 156
2022
Q1 		$864K Sell
3,632
-233
-6% -$54.7K 0.03% 136
2021
Q4 		$883K Buy
+3,865
New +$850K 0.04% 133

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stonegate Investment Group's CME Position: Q3 2025 in Review

Stonegate Investment Group increased its CME Group (CME) stake by 0.56% in Q3 2025, buying an estimated $2.18K and bringing the position to 1,432 shares worth $387K. The position accounts for 0.01% of the portfolio, ranked #283.

Stonegate Investment Group first reported a position in CME in Q4 2021 and has held it in 16 quarters since. The position peaked at $883K in Q4 2021. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Stonegate Investment Group held 1,432 shares of CME Group worth $387K as of Q3 2025.
  • Stonegate Investment Group bought 8 CME Group shares in Q3 2025, an estimated $2.18K.
  • CME Group made up 0.01% of Stonegate Investment Group's portfolio in Q3 2025, its #283 holding.
  • Stonegate Investment Group first reported a position in CME Group in Q4 2021 and has held it in 16 quarters since.
  • Stonegate Investment Group's CME Group position peaked at $883K in Q4 2021.
  • 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.